MedPath

GENERIC DEVICES CONSULTING, INC.

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Chemoembolization, Irinotecan Bead, Second Line Chemotherapy Treatment of Unresectable Metastatic Colorectal Cancer

Phase 1
Terminated
Conditions
Unresectable Metastatic Colo-rectal Cancer
Interventions
Procedure: Chemoembolization with irinotecan Bead
First Posted Date
2009-01-05
Last Posted Date
2018-09-07
Lead Sponsor
Generic Devices Consulting, Inc.
Target Recruit Count
4
Registration Number
NCT00816777
Locations
🇺🇸

Northwestern University, Chicago, Illinois, United States

🇺🇸

University of Colorado Cancer Center, Aurora, Colorado, United States

🇺🇸

Lahey Clinic, Burlington, Massachusetts, United States

© Copyright 2025. All Rights Reserved by MedPath